Early Phase 1 Leukaemia Trial, Recruiting NCT06890494 Sponsor: Beijing GoBroad Hospital Condition: Leukaemia
Back to Leukaemia

Early Phase 1 Leukaemia Trial, Recruiting

NCT06890494
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with acute B lymphocytic leukemia (a type of blood cancer) that has come back after treatment, has not responded to treatment, or where your own T cells cannot be used to make a CAR-T cell therapy.
  • Your cancer cells test positive for a protein called CD19 (confirmed by a lab test).
  • You are between 18 and 70 years old (inclusive).
  • Your doctors expect you to live for more than 3 months from the time you sign up for the trial.
  • You are reasonably able to carry out daily activities, as measured by a standard medical scoring system (confirm with trial site).
  • Your heart is pumping well (more than 50% efficiency), with no major abnormalities on a heart tracing test.
  • Your blood oxygen level is at a healthy level (92% or above).
  • Your kidneys and liver are functioning within acceptable ranges, based on blood tests.
  • If you are able to become pregnant or father a child, you agree to use reliable contraception during the study and for six months afterward, and you agree to inform the research team immediately if pregnancy occurs or is suspected.
  • You (or your legal guardian) understand and are willing to sign the consent form for the trial.

Who may not be able to join:

  • You have another serious illness that is not well controlled, such as an ongoing infection, heart failure, unstable chest pain, irregular heartbeat, serious lung disease, or a mental health condition.
  • You currently have another active cancer (other than the one being studied).
  • You have a serious infection that cannot be brought under control.
  • You test positive for active Hepatitis B, Hepatitis C, cytomegalovirus (CMV), or Epstein-Barr virus (EBV) infections in your blood (confirm with trial site for specific details).
  • You test positive for HIV (the virus that causes AIDS) or syphilis.
  • You have had a severe allergic reaction to a biological medicine or antibiotic in the past.
  • You received a stem cell transplant from a donor and then experienced a severe (grade 3–4) acute reaction where the donated cells attacked your body (a serious form of graft-versus-host disease).
  • You are currently pregnant or breastfeeding.
  • You have an active autoimmune disease (where your immune system attacks your own body) that requires ongoing treatment to suppress your immune system.
  • The trial doctors believe your participation could put you at increased risk or could affect the reliability of the trial results.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 8618911067969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Beijing GoBroad Hospital
Registry
ClinicalTrials.gov
Start date
18 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Treatment-Related Adverse Events (TRAEs); Severity of Treatment-Related Adverse Events; Frequency of Treatment-Related Adverse Events; Type of Treatment-Related Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov